• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质细胞功能障碍是路易体相关性帕金森病的关键发病机制吗?

Is Glial Dysfunction the Key Pathogenesis of -Linked Parkinson's Disease?

机构信息

Department of Neurology, School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Department of Research for Parkinson's Disease, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

出版信息

Biomolecules. 2023 Jan 15;13(1):178. doi: 10.3390/biom13010178.

DOI:10.3390/biom13010178
PMID:36671564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9856048/
Abstract

Leucine rich-repeat kinase 2 () is the most well-known etiologic gene for familial Parkinson's disease (PD). Its gene product is a large kinase with multiple functional domains that phosphorylates a subset of Rab small GTPases. However, studies of autopsy cases with LRRK2 mutations indicate a varied pathology, and the molecular functions of LRRK2 and its relationship to PD pathogenesis are largely unknown. Recently, non-autonomous neurodegeneration associated with glial cell dysfunction has attracted attention as a possible mechanism of dopaminergic neurodegeneration. Molecular studies of LRRK2 in astrocytes and microglia have also suggested that LRRK2 is involved in the regulation of lysosomal and other organelle dynamics and inflammation. In this review, we describe the proposed functions of LRRK2 in glial cells and discuss its involvement in the pathomechanisms of PD.

摘要

富含亮氨酸重复激酶 2(LRRK2)是最著名的家族性帕金森病(PD)的病因基因。其基因产物是一种具有多个功能结构域的大型激酶,可磷酸化一组 Rab 小分子 GTP 酶。然而,对具有 LRRK2 突变的尸检病例的研究表明存在多种病理学,LRRK2 的分子功能及其与 PD 发病机制的关系在很大程度上尚不清楚。最近,与神经胶质细胞功能障碍相关的非自主神经退行性变作为多巴胺能神经退行性变的可能机制引起了关注。对星形胶质细胞和小胶质细胞中 LRRK2 的分子研究也表明,LRRK2 参与调节溶酶体和其他细胞器的动态以及炎症。在这篇综述中,我们描述了 LRRK2 在神经胶质细胞中的拟议功能,并讨论了其在 PD 发病机制中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/3e0d7446e718/biomolecules-13-00178-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/509b5e7a70fa/biomolecules-13-00178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/46b78dff02ab/biomolecules-13-00178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/f5fc960ea60c/biomolecules-13-00178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/3e0d7446e718/biomolecules-13-00178-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/509b5e7a70fa/biomolecules-13-00178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/46b78dff02ab/biomolecules-13-00178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/f5fc960ea60c/biomolecules-13-00178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/9856048/3e0d7446e718/biomolecules-13-00178-g004.jpg

相似文献

1
Is Glial Dysfunction the Key Pathogenesis of -Linked Parkinson's Disease?胶质细胞功能障碍是路易体相关性帕金森病的关键发病机制吗?
Biomolecules. 2023 Jan 15;13(1):178. doi: 10.3390/biom13010178.
2
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.帕金森病相关 LRRK2 干扰星形胶质细胞介导的α-突触核蛋白清除。
Mol Neurobiol. 2021 Jul;58(7):3119-3140. doi: 10.1007/s12035-021-02327-8. Epub 2021 Feb 24.
3
LRRK2 G2019S and Parkinson's disease: insight from Neuroinflammation.LRRK2 G2019S 与帕金森病:神经炎症的新视角。
Postgrad Med J. 2023 Dec 21;100(1179):4-11. doi: 10.1093/postmj/qgad080.
4
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years.富含亮氨酸重复激酶2在神经胶质细胞中的相关功能:近年研究进展
Biochem Soc Trans. 2021 Jun 30;49(3):1375-1384. doi: 10.1042/BST20201092.
5
Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson's Disease.LRRK2 基因突变在帕金森病中的作用概述。
Biomolecules. 2023 May 16;13(5):845. doi: 10.3390/biom13050845.
6
The Role of LRRK2 in Intracellular Organelle Dynamics.LRRK2 在细胞内细胞器动态中的作用。
J Mol Biol. 2023 Jun 15;435(12):167998. doi: 10.1016/j.jmb.2023.167998. Epub 2023 Feb 9.
7
Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.LRRK2 导致 Rab GTPases 的磷酸化失调,从而引发神经退行性变。
Mol Neurodegener. 2018 Feb 13;13(1):8. doi: 10.1186/s13024-018-0240-1.
8
Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes.Rab12是LRRK2的调节剂,且其由受损溶酶体激活。
Elife. 2023 Oct 24;12:e87255. doi: 10.7554/eLife.87255.
9
Mechanisms of lysosomal tubulation and sorting driven by LRRK2.LRRK2 驱动的溶酶体小管化和分选的机制。
Biochem Soc Trans. 2024 Aug 28;52(4):1909-1919. doi: 10.1042/BST20240087.
10
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.帕金森病相关的G2019S LRRK2诱导的多巴胺能神经变性依赖于激酶和GTP酶活性。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17296-17307. doi: 10.1073/pnas.1922184117. Epub 2020 Jul 6.

引用本文的文献

1
Role of LRRK2 in axonal transport and Parkinson's disease.富亮氨酸重复激酶2(LRRK2)在轴突运输及帕金森病中的作用
Biochem J. 2025 Jun 25;482(13):BCJ20253133. doi: 10.1042/BCJ20253133.
2
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Models.评估神经炎症在LRRK2模型中对神经退行性变的作用。
Biomedicines. 2024 Jul 12;12(7):1555. doi: 10.3390/biomedicines12071555.
3
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.固有细胞类型特异性神经生物学调节的选择性多巴胺能神经毒性。

本文引用的文献

1
LRRK2-targeted Parkinson disease drug advances into phase III.针对LRRK2的帕金森病药物进入III期试验。
Nat Rev Drug Discov. 2023 Jan;22(1):3-5. doi: 10.1038/d41573-022-00212-0.
2
Parkinson disease-associated Leucine-rich repeat kinase regulates UNC-104-dependent axonal transport of Arl8-positive vesicles in .帕金森病相关富含亮氨酸重复激酶调节线虫中UNC-104依赖的Arl8阳性囊泡的轴突运输 。
iScience. 2022 Nov 2;25(12):105476. doi: 10.1016/j.isci.2022.105476. eCollection 2022 Dec 22.
3
Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid.
Neurotoxicology. 2024 Jul;103:266-287. doi: 10.1016/j.neuro.2024.06.016. Epub 2024 Jul 2.
4
LRRK2; Communicative Role in the Treatment of Parkinson's Disease and Ulcerative Colitis Overlapping.LRRK2 在治疗帕金森病和溃疡性结肠炎重叠中的交流作用。
CNS Neurol Disord Drug Targets. 2024;23(10):1177-1188. doi: 10.2174/0118715273270874231205050727.
5
The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.α-突触核蛋白病参与小胶质细胞稳态的破坏导致帕金森病的发病机制。
Cell Commun Signal. 2024 Jan 12;22(1):31. doi: 10.1186/s12964-023-01402-y.
6
Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice.抑制LRRK2激酶活性可挽救VPS35 p.D620N基因敲入小鼠纹状体多巴胺生理学缺陷。
NPJ Parkinsons Dis. 2023 Dec 18;9(1):167. doi: 10.1038/s41531-023-00609-7.
7
Influence of aging, mitochondrial dysfunction, and inflammation on Parkinson's disease.衰老、线粒体功能障碍及炎症对帕金森病的影响。
Neural Regen Res. 2024 Jun 1;19(6):1197-1198. doi: 10.4103/1673-5374.385873. Epub 2023 Sep 22.
8
Infectious Microorganisms Seen as Etiologic Agents in Parkinson's Disease.传染性微生物被视为帕金森病的病因。
Life (Basel). 2023 Mar 16;13(3):805. doi: 10.3390/life13030805.
实质边界巨噬细胞调节脑脊液的流动动力学。
Nature. 2022 Nov;611(7936):585-593. doi: 10.1038/s41586-022-05397-3. Epub 2022 Nov 9.
4
Lysosomal positioning regulates Rab10 phosphorylation at LRRK2 lysosomes.溶酶体定位调节 LRRK2 溶酶体上 Rab10 的磷酸化。
Proc Natl Acad Sci U S A. 2022 Oct 25;119(43):e2205492119. doi: 10.1073/pnas.2205492119. Epub 2022 Oct 18.
5
A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation.正向通路驱动 LRRK2 激酶的膜募集和激活。
Elife. 2022 Sep 23;11:e79771. doi: 10.7554/eLife.79771.
6
The endoplasmic reticulum contributes to lysosomal tubulation/sorting driven by LRRK2.内质网有助于 LRRK2 驱动的溶酶体小管化/分拣。
Mol Biol Cell. 2022 Nov 1;33(13):ar124. doi: 10.1091/mbc.E22-04-0139. Epub 2022 Aug 31.
7
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.帕金森病LRRK2 G2385R风险变异体的病理生理学评估
NPJ Parkinsons Dis. 2022 Aug 5;8(1):97. doi: 10.1038/s41531-022-00367-y.
8
Association of a common genetic variant with Parkinson's disease is mediated by microglia.常见遗传变异与帕金森病的关联是由小胶质细胞介导的。
Sci Transl Med. 2022 Jul 27;14(655):eabp8869. doi: 10.1126/scitranslmed.abp8869.
9
The Mechanism and Function of Glia in Parkinson's Disease.帕金森病中胶质细胞的机制与功能
Front Cell Neurosci. 2022 May 26;16:903469. doi: 10.3389/fncel.2022.903469. eCollection 2022.
10
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.DLN201 作为 LRRK2 抑制剂用于帕金森病的临床前和临床评估。
Sci Transl Med. 2022 Jun 8;14(648):eabj2658. doi: 10.1126/scitranslmed.abj2658.